Disclosure
Ms Chelsey Hoffmann reports personal fees from SPR Therapeutics and Nalu Medical, outside the submitted work. Dr Michael E Schatman is a research consultant for Modoscript and part of the Scientific Steering Committee of Collegium Pharmaceutical, outside the submitted work. The authors report no other conflicts of interest in this work.